Status:
COMPLETED
Tryptophan Depletion in Acute Mania
Lead Sponsor:
Rambam Health Care Campus
Collaborating Sponsors:
Beersheva Mental Health Center
Conditions:
Bipolar Disorder
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Serotonin (5-HT) is important in mood regulation and is believed to play a major role in the pathophysiology of major depression (MD). Selective serotonin reuptake inhibitors (SSRIs) are currently the...
Eligibility Criteria
Inclusion
- Acute mania
- Ability to provide written informed consent
Exclusion
- Mixed affective states
- Suicidal ideation
- Uncontrolled systemic illness
Key Trial Info
Start Date :
March 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2008
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00192725
Start Date
March 1 2003
End Date
June 1 2008
Last Update
August 25 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rambam Medical Center
Haifa, Israel, 31096